Wang Grace, Lu Louie, Gold Laura S, Bailey Jeannie F
Clinical Research, Hinge Health, Inc, San Francisco, CA, USA.
Clinical Learning, Evidence and Research Center, University of Washington, Seattle, WA, USA.
J Pain Res. 2023 Jul 27;16:2609-2618. doi: 10.2147/JPR.S412081. eCollection 2023.
In-person, conservative care may decrease opioid use for chronic musculoskeletal (MSK) pain, but the impact of digitally delivered conservative care on opioid use is unknown. This study examines associations between a digital MSK program and opioid initiation and prescriptions among opioid naive adults with chronic MSK pain.
This observational study used commercial medical and pharmacy claims data to compare digital MSK program members to matched physical therapy (PT) patients. Outcomes were any opioid prescriptions and opioid prescriptions per 100 participants within the 12-months after starting a digital MSK program. After propensity-score matching, we conducted multivariate regression models that controlled for demographic, comorbidity, and baseline MSK healthcare use.
The study included 4195 members and 4195 matched PT patients. For opioid initiation, 7.89% (95% Confidence Interval [CI]: 7.07%, 8.71%) of members had opioid prescriptions within 12 months after starting the digital MSK program versus 13.64% (95% CI: 12.60%, 14.67%) of matched PT patients (p < 0.001). Members had significantly fewer opioid prescriptions (16.73 per 100 participants; 95% CI: 14.11, 19.36) versus PT patients (22.36 per 100 participants; 95% CI: 19.99, 24.73). Members had lower odds (OR: 0.52, 95% CI: 0.45, 0.60) of initiating opioids and significantly fewer prescriptions per 100 participants (beta: -6.40, 95% CI: -9.88, -2.93) versus PT patients after controlling for available confounding factors.
An MSK program that delivers conservative care digitally may be a promising approach for decreasing opioid initiation among individuals with chronic MSK pain given the limitations of the observational design and matching on only available covariates.
面对面的保守治疗可能会减少慢性肌肉骨骼(MSK)疼痛患者的阿片类药物使用,但数字化提供的保守治疗对阿片类药物使用的影响尚不清楚。本研究调查了一个数字化MSK项目与慢性MSK疼痛的阿片类药物初用者和阿片类药物处方之间的关联。
这项观察性研究使用商业医疗和药房报销数据,将数字化MSK项目成员与匹配的物理治疗(PT)患者进行比较。结局指标为开始数字化MSK项目后12个月内的任何阿片类药物处方以及每100名参与者的阿片类药物处方。在倾向得分匹配后,我们进行了多变量回归模型,该模型控制了人口统计学、合并症和基线MSK医疗保健使用情况。
该研究纳入了4195名成员和4195名匹配的PT患者。在开始数字化MSK项目后的12个月内,7.89%(95%置信区间[CI]:7.07%,8.71%)的成员有阿片类药物处方,而匹配的PT患者为13.64%(95%CI:12.60%,14.67%)(p<0.001)。成员的阿片类药物处方明显少于PT患者(每100名参与者16.73张;95%CI:14.11,19.36)(每100名参与者22.36张;95%CI:19.99,24.73)。在控制了可用的混杂因素后,与PT患者相比,成员开始使用阿片类药物的几率较低(OR:0.52,95%CI:0.45,0.60),且每100名参与者的处方明显更少(β:-6.40,95%CI:-9.88,-2.93)。
考虑到观察性设计的局限性以及仅对可用协变量进行匹配,数字化提供保守治疗的MSK项目可能是减少慢性MSK疼痛患者阿片类药物初用的一种有前景的方法。